1. Brooks F, Lau S, Baddour E, Rao P, Bhagat S.
Thromboprophylaxis in Spinal Surgery – Current UK Practice.
J Spine. 2012; 1(121):2.
2. Al-Dujaili TM, Majer CN, Madhoun TE, Kassis SZ, Saleh AA.
Deep venous thrombosis in spine surgery patients: incidence
and hematoma formation. Int Surg.2012; 97(2):150-4. doi:
10.9738/CC71.1.
3. Alvarado AM, Porto GBF, Wessell J, Buchholz AL, Arnold PM.
Venous Thromboprophylaxis in Spine Surgery. Global Spine
J.2020; 10(1 Suppl):65S-70S. doi:
10.1177/2192568219858307.
4. Oda T, Fuji T, Kato Y, Fujita S, Kanemitsu N. Deep venous
thrombosis after posterior spinal surgery. Spine (Phila Pa
1976). 2000; 25(22):2962-7. doi: 10.1097/00007632-
200011150-00019.
5. Fawi H, Saba K, Cunningham A, et al. Venous
thromboembolism in adult elective spinal surgery: a tertiary
center review of 2181 patients. Bone Joint J. 2017; 99-B
(9):1204-1209. doi: 10.1302/0301-620X.99B9.BJJ-2016-
1193.R2.
6. Rahbarian Yazdi F, Mehrad-Majd H, Gholami S, et al. A
Comparison between Pre-Incisional and Intraoperative
Lidocaine Infiltration on Post-Incisional Surgical Pain in
Microdiscectomy Surgery: A Randomized Clinical Trial Study.
Arch Bone Jt Surg. 2023; 11(10):635-640. doi:
10.22038/ABJS.2023.63374.3059.
7. Cullari M, Aguer S, Lloyd R. Unexpected Bacteriological
Finding Using Sonication in Revision Spine Surgery (Report of
Two Cases). Arch Bone Jt Surg. 2023; 11(6):429-433. doi:
10.22038/ABJS.2023.71877.3353.
8. Mashhadinejad, H, Sarabi E, Mashhadinezhad S, Ganjeifar B.
Clinical Outcomes after Microdiscectomy for Recurrent
Lumbar Disk Herniation: A Single-Center Study. Arch Bone Jt
Surg. 2018; 6(5):397-401.
9. Tominaga H, Setoguchi T, Tanabe F, et al. Risk factors for
venous thromboembolism after spine surgery. Medicine
(Baltimore). 2015; 94(5):e466. doi:
10.1097/MD.0000000000000466.
10. Bono CM, Watters III WC, Heggeness MH, et al. An evidencebased clinical guideline for the use of antithrombotic
therapies in spine surgery. Spine J. 2009; 9(12):1046-51. doi:
10.1016/j.spinee.2009.09.005.
11. Anderson DR, Dunbar M, Murnaghan J, et al. Aspirin or
rivaroxaban for VTE prophylaxis after hip or knee
arthroplasty. N Engl J Med. 2018; 378(8):699-707. doi:
10.1056/NEJMoa1712746.
12. Linkins L-A. Ground-Breaking Trial Shows Aspirin Is As
Effective As Rivaroxaban Following Hip and Knee
Arthroplasty. The Hematologist. 2018; 15(4). doi:
10.1182/hem.V15.4.8714. 13. Azboy I, Barrack R, Thomas A, Haddad F, Parvizi J. Aspirin and the prevention of venous thromboembolism following
total joint arthroplasty: commonly asked questions. Bone Joint J.
2017; 99-B (11):1420-1430. doi: 10.1302/0301-
620X.99B11.BJJ-2017-0337.R2.
14. Kohli V, Sriramoju VB, Forrest T. A meta-analysis comparing
aspirin versus rivaroxaban for venous thromboembolism
prophylaxis in patients with knee or hip arthroplasty. Journal
of the American College of Cardiology. 2019; 73(9S1):1933-
1933.
15. Arti H, Rouzbahani R. Comparing the Effectiveness Results of
Heparin and Enoxaparin after Total Hip Arthroplasty. Journal
of Isfahan Medical School. 2013; 31(231).
16. Michot M, Conen D, Holtz D, et al. Prevention of deep-vein
thrombosis in ambulatory arthroscopic knee surgery: A
randomized trial of prophylaxis with low–molecular weight
heparin. Arthroscopy.2002; 18(3):257-63. doi:
10.1053/jars.2002.30013.
17. Vulcano E, Gesell M, Esposito A, Ma Y, Memtsoudis SG,
Gonzalez Della Valle A. Aspirin for elective hip and knee
arthroplasty: a multimodal thromboprophylaxis protocol. Int
Orthop. 2012; 36(10):1995-2002. doi: 10.1007/s00264-012-
1588-4.
18. Kroegel C, Reissig A. Principle mechanisms underlying
venous thromboembolism: epidemiology, risk factors,
pathophysiology and pathogenesis. Respiration.2003;
70(1):7-30. doi: 10.1159/000068427.
19. Jaureguito JW, Greenwald AE, Wilcox JF, Paulos LE,
Rosenberg TD. The incidence of deep venous thrombosis
after arthroscopic knee surgery. Am J Sports Med.1999;
27(6):707-10. doi: 10.1177/03635465990270060401.